Lundbeck
HLUN-B.CO
#2602
Rank
HK$53.61 B
Marketcap
HK$54.04
Share price
-0.35%
Change (1 day)
-1.79%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): HK$5.95

According to Lundbeck's latest financial reports the company's current EPS (TTM) is HK$5.97. In 2025 the company made an earnings per share (EPS) of HK$3.97 an increase over its 2024 EPS that were of HK$3.47.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$5.9549.8%
2025HK$3.9714.5%
2024HK$3.4729.29%
2023HK$2.6823.09%
2022HK$2.1837.26%
2021HK$1.59-84.61%
2020HK$10.33-24.61%
2019HK$13.70-42.06%
2018HK$23.6440.7%
2017HK$16.80146.26%
2016HK$6.82-120.48%
2015-HK$33.303231.32%
2014-HK$1.00-115.78%
2013HK$6.33-23.36%
2012HK$8.27-48.01%
2011HK$15.90-9.68%
2010HK$17.6013.72%
2009HK$15.4824.32%
2008HK$12.45-6.05%
2007HK$13.2581.77%
2006HK$7.29-16.76%
2005HK$8.76-17.58%
2004HK$10.63